ESBL producing Pseudomonas aeruginosa resistant to CAZ, ATM, FEP, borderline resistant to PIP, susceptible to TIM and TZP. Note the synergy between TIM.

Slides:

Advertisements

Similar presentations

Development of Resistance mechanisms in Pseudomonas aeruginosa

Advertisements

TREATMENT FOR SUPERIMPOSED PSEUDOMONAS AERUGINOSA INFECTION.

Antimicrobial resistance (AMR) profiling in Escherichia coli from farmed and wild animals in the Mekong delta of Vietnam Nguyen Thi Nhung Oxford University.

Edward L. Goodman, MD Core Faculty Hospital Epidemiologist June 27, 2013.

Emerging Antimicrobial Resistance in Texas The new ESBLs.

(classical) genetics causality phenotype DNA ‘reverse’ genetics.

BSAC Standardised Disc Susceptibility Test User Group Day. Royal College of Physicians, London. 8 June 2007 Susceptibility testing of mucoid Pseudomonas.

AMINOGLYCOSIDES Streptomycin* Gentamicin* Tobramycin* Amikacin Kanamycin Neomycin(topical) * most commonly used Antibacterial Spectrum Bactericidal ( exclusive.

Klebsiella oxytoca and K1 enzyme

Welcome to the CDS Workshop Jeanette Pham Syd Bell Hobart 2011.

A review and update of the CDS test CDS Workshop ASM 2009 Perth.

WELCOME to the CDS WORKSHOP Sydney Excel Spreadsheet for Registration.

Plate 1a: Staphylococcus aureus resistant to penicillin (P0.5) only. Note the annular radius of the zone of inhibition of 9.5 mm around the cefoxitin (FOX.

Plasmid mediated Metallo-Beta- Lactamase (MBL) Plasmid mediated Hydrolyses all beta-lactam (except aztreonam) Inhibited by EDTA Binds zinc (Zn 2+ ) Pseudomonas.

Sorting Out Antibiotics: A systematic approach to antibiotic selection Kenneth Alexander, M.D., Ph.D. Associate Professor of Pediatrics and Microbiology.

Antimicrobial resistance surveillance in Ireland Results of invasive Pseudomonas aeruginosa infection (blood/CSF) surveillance, 2009 **** Data as of 01/12/2010.

n°10 : Klebsiella pneumoniae

COL Helen Viscount, PhD, D(ABMM) LTC Steven Mahlen, PhD, D(ABMM)

MDR Organisms in Holy Family Hospital Rawalpindi

ANTIBIOTICS (Foundation Block, Microbiology).

Ceftazidime resistance in a Salmonella enterica serotype Bareilly in Ireland N.DeLappe, D Morris, C.O’Hare, E.Costello, G.Corbett-Feeney and M.Cormican.

Antimicrobial resistance surveillance in Ireland Results of invasive Escherichia coli infection (blood/CSF) surveillance, 2009 **** Data as of 01/12/2010.

Resistance in Pseudomonas aeruginosa and Acinetobacter spp. from blood in the UK and Ireland Rosy Reynolds, Russell Hope, BSAC Working Party.

Bacterial Resistance in China

EARS-Net data on Antimicrobial Resistance in Ireland, Q3 2015

N.meningitidis Ceftriaxone- children and adults Cefotaxime- neonates Ampicillin Chloramphenicol N. gonorrhea Ceftriaxone Cefotaxime Ciprofloxacin Spectinomycin.

Antimicrobial resistance surveillance in Ireland Results of invasive Klebsiella pneumoniae infection (blood/CSF) surveillance, 2009 **** Data as of 01/12/2010.

EARS-Net data on antimicrobial resistance in Ireland Quarter st March 2016.

Multi-Resistant Gram Negative Microorganisms St Elisabeth Hospital Curacao.

(Ambler class A, Bush group 2) Inhibited by CA

Using Nursing Home Antibiograms To Improve Antibiotic Prescribing and Delivery Training Slides for Nursing Home Nurses Comprehensive Antibiogram Toolkit.

Prof. Hee Joo, Lee June, 8, Introduction P. aeruginosa –Nosocomial pathogen –Ability to acquire resistance to several antibiotics –Emergence of.

C-158 Genetic and Biochemical Characterisation of OXA-405, a New Extended Spectrum Class D -Lactamase from Serratia marcescens L. Dortet1,2, S. Oueslati1,

Current Status of Antimicrobial Resistance

8th Annual Infection Prevention Conference 23rd June 2011, Harrogate

Serotypes, genotypes and antimicrobial resistance patterns of human diarrhoeagenic Escherichia coli isolates circulating in southeastern China Y. Chen,

EARS-Net data on Antimicrobial Resistance in Ireland, Q

Standardisation – What does this mean for the CDS?

Table 2: Percentage of cross resistance among tested antibiotics

International Journal of Infectious Diseases

The Role of the Microbiology Laboratory in AMS programs

Antimicrobial Agents Antibiotics:

F.M. MacKenzie, C.A. Miller, I.M. Gould

Emergence of Klebsiella pneumoniae with an AmpC(DHA-1) and blaSHV-11 in a Belgian hospital. Timothy Vanwynsberghe1, Katia Verhamme2, Marijke Raymaekers3,

An Introduction to Medicinal Chemistry 3/e

Clinico-Pathological Conference (CPC) Meet

Antibiotics sensitivity of microorganism causing nosocomial infections

Metallo-β-lactamase-producing Pseudomonas aeruginosa in the Netherlands: the nationwide emergence of a single sequence type A.K. Van der Bij, D. Van.

Development of resistance in Pseudomonas aeruginosa obtained from patients with cystic fibrosis at different times F.B. Spencker, L. Staber, T. Lietz,

EARS-Net data on Antimicrobial Resistance in Ireland, Q

Antibiotics: What are they & How they are used

BSAC Bacteraemia Resistance Surveillance Update 2013

C th Interscience Conference on Antimicrobial Agents and Chemotherapy October 25-28, Washington, DC Examining Temocillin Activity in Combination.

L. Poirel, P. Nordmann Clinical Microbiology and Infection

Alasdair P. MacGowan, Caroline Rynn, Mandy Wootton, Karen E. Bowker, H

The need for new antibiotics

EXTENDED SPECTRUM β-LACTAMASE PRODUCING GRAM NEGATIVE BACTERIA ISOLATED FROM INFECTED WOUND OF ORTHOPEDIC PATIENTS Shwe Phyu Aung , Thandar Win Maung,

Making sense of antimicrobial use and resistance surveillance data: application of ARIMA and transfer function models D.L. Monnet, J.-M. López-Lozano,

Evaluation of a diagnostic flow chart for detection and confirmation of extended spectrum β-lactamases (ESBL) in Enterobacteriaceae S. Polsfuss, G.V.

Phenotypic detection of extended-spectrum β-lactamase production in Enterobacteriaceae: review and bench guide L. Drieux, F. Brossier, W. Sougakoff,

Β-LACTAM ANTIBIOTICS THIENAMYCIN MONOBACTAMS β-LACTAM INHIBITORS.

Highly antibiotic-resistant Acinetobacter baumannii clinical isolates are killed by the green tea polyphenol (–)-epigallocatechin-3-gallate (EGCG) A.

Jacques Sirot Clinical Microbiology and Infection

Profile of Pseudomonas aeruginosa resistance by country and antibiotic

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group† H. Goossens Clinical.

Aminoglycosides: Bactericidal Inhibitors of Protein Synthesis

Potentiation of legacy antibiotics against P

Double-disk diffusion and Etest ESBL detection tests.

Serotypes, genotypes and antimicrobial resistance patterns of human diarrhoeagenic Escherichia coli isolates circulating in southeastern China Y. Chen,

Presentation transcript:

ESBL producing Pseudomonas aeruginosa resistant to CAZ, ATM, FEP, borderline resistant to PIP, susceptible to TIM and TZP. Note the synergy between TIM and CAZ (key hole) and the modest synergy between TZP and ATM.

Plasmid mediated ESBL in Pseudomonas aeruginosa Group 2be (class A enzyme) Inhibited by clavulanate, tazobactam Hydrolyse ceftazidime, aztreonam Key hole seen with Timentin /ceftazidime Rare ESBL : PER-1, VEB-1

The ESBL producing Pseudomonas aeruginosa is also resistant to the aminoglycosides, gentamicin (CN 10), tobramicin (TOB 10), amikacin (AK 30) and ciprofloxacin (CIP 2.5).